GHRP-6 alternatives.

10 compounds compared to GHRP-6, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Why people look for an alternative

The specific reason people leave GHRP-6 is hunger. It was the prototype of the growth hormone secretagogue class and acts as a strong appetite stimulant through the ghrelin receptor, which is useful in some research contexts and unwanted in most others. That is the alternatives search in one line: the same pituitary signal without the eating. Ipamorelin was designed for exactly this, characterized as a selective secretagogue that raises GH with less accompanying cortisol and prolactin release. What no alternative in this class fixes is the regulatory picture: GHRP-6 is not approved for any therapeutic indication, and neither are its descendants, all of which WADA prohibits at all times.

What you're comparing against
GHRP-6
D tier · 38/100Research / preclinical

GHRP-6 (growth hormone-releasing peptide-6) is a synthetic hexapeptide with the sequence His-D-Trp-Ala-Trp-D-Phe-Lys-NH2.

Ranked by evidence · strongest first
  1. 01
    GHRP-1
    D tierResearch / preclinical
    growth hormone-releasing peptide-1

    Acts through the ghrelin-receptor agonism pathway, like GHRP-6. Research / preclinical.

  2. 02
    GHRP-2
    D tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like GHRP-6. Research / preclinical.

  3. 03
    Hexarelin
    D tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like GHRP-6. Research / preclinical.

  4. 04
    Ipamorelin
    F tierResearch / preclinical

    Acts through the ghrelin-receptor agonism pathway, like GHRP-6. Research / preclinical.

  5. 05
    Human Growth Hormone
    S tierFDA-approved
    HGH · somatropin

    Same category: growth hormone. FDA-approved.

  6. 06
    Tesamorelin
    A tierFDA-approved
    Egrifta

    Same category: growth hormone. FDA-approved.

  7. 07
    Sermorelin
    C tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  8. 08
    ACE-031
    D tierIn human trials
    ramatercept · ActRIIB-Fc

    Same category: growth hormone. In human trials.

  9. 09
    CJC-1295
    F tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

  10. 10
    IGF-1 LR3
    F tierResearch / preclinical

    Same category: growth hormone. Research / preclinical.

How this list is built

An “alternative” here means a compound that shares GHRP-6's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds